Tonghua Dongbao begins share repurchase program

Tonghua Dongbao Pharmaceutical Co., Ltd. initiated its first share repurchase through centralized bidding transactions on November 6, 2025. The company repurchased 143,500 shares, representing 0.01% of its total share capital. The repurchase price was yuan 9.00 per share, with a total transaction amount of yuan 1,291,500 (excluding transaction fees).

The repurchase program, proposed by chairman Li Jiahong and approved by the board on October 17, 2025, aims to use company funds for employee stock ownership plans or equity incentives. The board approved a total repurchase value of yuan 20,000,000 to yuan 40,000,000, with a maximum price not exceeding yuan 10 per share.

The repurchase period extends from October 17, 2025, to April 16, 2026. Tonghua Dongbao committed to adhering strictly to relevant regulations, ensuring timely disclosure of progress and cautioning investors about potential risks.